Goodwin Biotechnology Inc., a full service contract biomanufacturing company, and Hyprocell LLC, a provider of clinical cell line development services, have entered into a collaboration agreement to create a business model enabling customers to access their combined services. The collaboration aims to enhance clinical development services by integrating cDNA synthesis, cloning into mammalian expression vector, transfection, clone selection and stable cell line development with cell banking, u...